QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)

Corvus Pharmaceuticals (CRVS) SEC Filings & 10K Form

$1.48
+0.02 (+1.02%)
(As of 09:56 AM ET)

Recent Corvus Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/01/2024
4:57 PM
Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
12:31 PM
Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
Form SC 13G
02/13/2024
5:27 PM
Corvus Pharmaceuticals (Subject)
MILLER RICHARD A MD (Filed by)
Form SC 13G/A
09/06/2023
6:39 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
4:03 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
3:54 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
11:15 PM
Corvus Pharmaceuticals (Filer)
Form EFFECT
04/28/2023
8:00 AM
Corvus Pharmaceuticals (Filer)
Form DEF 14A
04/28/2023
8:01 AM
Corvus Pharmaceuticals (Filer)
Form DEFA14A
04/24/2023
8:01 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CRVS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners